SCHEMBL7125073

SCHEMBL7125073

COc1cc(C(O)C(Cl)(Cl)Cl)ccc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.58
CYP3A4 P08684 1/20 0.58
BLM P54132 2/20 0.57
NFKB1 P19838 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
PMP22 Q01453 1/20 0.55
SLC22A3 O75751 1/20 0.51
MAOB P27338 1/20 0.48
BCHE P06276 2/20 0.48
TYR P14679 2/20 0.48
ACHE P22303 2/20 0.48
TRPA1 O75762 1/20 0.46
CYP19A1 P11511 1/20 0.46
CA2 P00918 2/20 0.45
NR3C1 P04150 1/20 0.45
GAA P10253 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127149 0.86 TUBB4A (0.55) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL7128355 0.83 TSHR (0.58) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL28445738 0.82 ALDH1A1 (0.48) TSHRCYP3A4BLMNFKB1PMP22
SCHEMBL7120793 0.80 ABL1 (0.42) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL705159 0.80 TSHR (0.68) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL7901872 0.80 TSHR (0.68) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL15553306 0.78 TSHR (0.66) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL7926790 0.78 TSHR (0.61) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL1301569 0.78 TSHR (0.66) TSHRCYP3A4BLMNFKB1NPSR1
SCHEMBL29466173 0.78 TSHR (0.66) TSHRCYP3A4BLMNFKB1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030144541-A1 Process for preparing alpha-halogenated retones RHODIA CHIMIE (FR) 2003-07-31 US claimed
EP-1250303-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2002-10-23 EP claimed
WO-2001055067-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2001-08-02 WO claimed
US-20030144541-A1 Process for preparing alpha-halogenated retones RHODIA CHIMIE (FR) 2003-07-31 US disclosed
EP-1250303-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2002-10-23 EP disclosed
WO-2001055067-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144541-A1 Process for preparing alpha-halogenated retones ADH1A, ADH1C, RER1 TSHR 1088/4885CYP3A4 492/4885BLM 1548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.